Radiation Safety and External Radiation Exposure Rate of Patients Receiving I-131 Therapy for Hyperthyroidism and Remnant Ablation as Outpatient: An Institutional Experience

被引:1
|
作者
Bhatia, Nisha [1 ]
Dhingra, Vandana K. [2 ]
Mittal, Pulkit [1 ]
Saini, Sunil [3 ]
机构
[1] Swami Rama Rama Himalayan Univ SRHU, Canc Res Inst, Dept Nucl Med, Dehra Dun 248016, Uttarakhand, India
[2] All India Inst Med Sci AIIMS, Dept Nucl Med, Rishikesh, Uttarakhand, India
[3] Swami Rama Himalayan Univ, Canc Res Inst, Dept Surg Oncol, Dehra Dun, Uttarakhand, India
关键词
radioiodine therapy; thyrotoxicosis; ablation; outpatient; radiation exposure; RADIOIODINE I-131; CARCINOMA;
D O I
10.1055/s-0043-1771285
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective Our objective was to study the radiation exposure rate as function of time in the administration of radioiodine iodine-131 (I-131) for the treatment of thyrotoxicosis or Graves' disease and remnant ablation on an outpatient basis at the Department of Nuclear Medicine, and also, to study the impact of revised discharge criteria for radioiodine therapy enforced by the Atomic Energy Regulatory Board (AERB) of India. Materials and Methods This study included patients who underwent low-dose radioiodine therapy using I-131. Patients were classified into two different groups, that is, group A and group B. Group A included patients receiving low dose I-131 for the treatment of thyrotoxicosis, whereas group B included patients receiving I-131 therapy for the ablation of residual thyroid tissue after total thyroidectomy. The radiation exposure rate was measured using a radiation detector in milli roentgen per hour (mR/h) at 5 cm distance of stomach and neck levels and with the patient standing at the distance of 1 m after oral administration of I-131 at 0, 1, and 2 hours. Results A total of 134 (17 males and 117 females) patients were included in the study. Group A comprised 102 (14 male and 88 females) patients and group B of 32 (3 males and 29 females) patients. At the neck level, the average exposure rate in group A versus group B after 0, 1, and 2 hours was observed to be 6.9 versus 22.27 mR/h, 33.67 versus 43.39 mR/h, and 41.75 versus 48.90 mR/h, respectively. At the stomach level, the exposure rate was 23.65 versus 71.32 mR/h, 13.27 versus 48.45 mR/h, and 9.91 versus 39.43 mR/h after 0, 1, and 2 hours, respectively. At a distance of 1 m, the exposure rate was 1.31 versus 2.99 mR/h, 1.05 versus 2.58 mR/h, and 0.92 versus 2.21 mR/h, respectively. Conclusion Exposure rate measured for patients treated with up to 1,110 MBq (30 mCi) of I-131 was under permissible limits as per revised discharged limits, that
引用
收藏
页码:203 / 207
页数:5
相关论文
共 50 条
  • [41] Experience in radiation safety recommendations to patients after I-131 administration for differentiated thyroid carcinoma - Calculated doses to family members and public applying the line source model
    Kotzassarlidou, M.
    Kalathas, T.
    Raptou, K.
    Makridou, A.
    Salem, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S267 - S267
  • [42] Current practices in radioiodine I-131 therapy for Differentiated Thyroid Carcinoma (DTC) in Greece: Some practical and radiation protection considerations based on measurements of dose rates and I-131 retention of patients at discharge
    Samartzis, A. P.
    Mavrokefalos, P.
    Molfetas, M.
    Datseris, I.
    Alevizaki, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S341 - S341
  • [43] Patients with recurrent glioblastorna rnultiforrne Initial experience with p-[131I]iodo-L-phenylalanine and external beam radiation therapy
    Verburg, F. A.
    Sweeney, R.
    Haenscheid, H.
    Diessl, S.
    Israel, I.
    Loehr, M.
    Vince, G. H.
    Flentje, M.
    Reiners, C.
    Samnick, S.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2013, 52 (01): : 36 - 42
  • [44] The Study of External Dose Rate and Retained Body Activity of Patients Receiving 131I Therapy for Differentiated Thyroid Carcinoma
    Zhang, Haiying
    Jiao, Ling
    Cui, Songye
    Wang, Liang
    Tan, Jian
    Zhang, Guizhi
    He, Yajing
    Ruan, Shuzhou
    Fan, Saijun
    Zhang, Wenyi
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2014, 11 (10) : 10991 - 11003
  • [45] Pediatric 131I-MIBG Therapy for Neuroblastoma: Whole-Body 131I-MIBG Clearance, Radiation Doses to Patients, Family Caregivers, Medical Staff, and Radiation Safety Measures
    Willegaignon, Jose
    Crema, Karin Paola
    Oliveira, Nathalie Canhameiro
    Pelissoni, Rogerio Alexandre
    Coura-Filho, George Barberio
    Sapienza, Marcelo Tatit
    Buchpiguel, Carlos Alberto
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (08) : 572 - 578
  • [46] Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy
    Kusakabe, Kiyoko
    Yokoyama, Kunihiko
    Ito, Koichi
    Shibuya, Hiroshi
    Kinuya, Seigo
    Ito, Mitsuru
    Higashi, Tatsuya
    Togawa, Takashi
    Koizumi, Kiyoshi
    Yoshimura, Mana
    Uchiyama, Mayuki
    Okamoto, Takahiro
    Kanaya, Shinichi
    Kanaya, Kazuko
    Yoneyama, Tatsuya
    Ikebuchi, Hideharu
    Yanagida, Sachiko
    Shibata, Keigo
    Segawa, Koji
    Yamamoto, Atsushi
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (04) : 370 - 378
  • [47] Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer
    Ceccarelli, C
    Battisti, P
    Gasperi, M
    Fantuzzi, E
    Pacini, F
    Gualdrini, G
    Pierantoni, MC
    Luciani, A
    Djokich, D
    Pinchera, A
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (10) : 1716 - 1721
  • [48] Thyroid remnant ablation using 1,110 MBq of I-131 after total thyroidectomy: regulatory considerations on release of patients after unsealed radioiodine therapy
    Kiyoko Kusakabe
    Kunihiko Yokoyama
    Koichi Ito
    Hiroshi Shibuya
    Seigo Kinuya
    Mitsuru Ito
    Tatsuya Higashi
    Takashi Togawa
    Kiyoshi Koizumi
    Mana Yoshimura
    Mayuki Uchiyama
    Takahiro Okamoto
    Shinichi Kanaya
    Kazuko Kanaya
    Tatsuya Yoneyama
    Hideharu Ikebuchi
    Sachiko Yanagida
    Keigo Shibata
    Koji Segawa
    Atsushi Yamamoto
    Annals of Nuclear Medicine, 2012, 26 : 370 - 378
  • [49] Radiation dose rate of I-131 in patients with differentiated thyroid carcinoma; effect of administrated activity, admission number and TSH level on retention curve
    Moslehi, M.
    Pashazadeh, A. Mahmoud
    Assadi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S600 - S600
  • [50] Radiation exposure in nurses during care of 131I-MIBG therapy for pediatric patients with high-risk neuroblastoma
    Yuka Taniguchi
    Hiroshi Wakabayashi
    Anri Inaki
    Daiki Kayano
    Masako Yamada
    Seigo Kinuya
    Annals of Nuclear Medicine, 2020, 34 : 441 - 447